Skip to main content
Premium Trial:

Request an Annual Quote

GenomeDx, Mayo Expand Research Agreement

NEW YORK (GenomeWeb) – GenomeDx announced today an expansion of its research agreement with the Mayo Clinic to start a validation study for the expanded use of GenomeDx's Decipher Prostate Cancer Classifier.

GenomeDx will have continued access to clinical data from Mayo's cohort of prostate cancer samples, enabling the San Diego-based firm to conduct longer-term follow-up and evaluation of biomarkers. The partners began collaborating in 2009, and in 2013 they expanded their deal to include an exclusive license to certain co-developed and Mayo-developed intellectual property.

The Decipher test analyzes whole genomes to profile RNA expression signatures. It measures the aggressiveness of prostate cancer in patients who have had a prostatectomy and classifies a patient's risk of disease progression, metastasis, and prostate-related death after a prostatectomy.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.